ProMIS is focused on development of antibody therapeutics targeting toxic proteins implicated in Alzheimer’s, ALS and multiple system atrophy. NASDAQ:PMN

ID: 3875793315

linkhttp://promisneurosciences.com/ calendar_today06-10-2015 00:40:18